PeptideBase
Back to Database
evidence varies by claim

AJP001

AJP001

Immune & Inflammatory

AJP001 is indexed as peptide in the PeptideBase article library. It is referenced in “Can a Peptide Vaccine Target IL-17A? What a 20-Person Phase 1 Trial Does—and Does Not—Show”. This page groups the relevant coverage; evidence strength, safety, and clinical relevance depend on the specific claim and source.

Research status: evidence varies by claim

Deep Dives on AJP001

Start here for the plain-English articles connected to this peptide.

Research & Evidence9 min read

Can a Peptide Vaccine Target IL-17A? What a 20-Person Phase 1 Trial Does—and Does Not—Show

What the 20-person FPP003 phase 1 trial shows about IL-17A peptide-vaccine safety and antibody responses—and why it does not prove neutralization or disease benefit.

Read article

Quick Facts

Origin
Named peptide referenced in PeptideBase coverage
Category
Immune & Inflammatory

Research Areas

Research & Evidence

Tags

ajp001peptidenamed peptide